| Analysis | Metabolite Name | Measured Value | Units | Diagnosis | Dysplasia |
|---|---|---|---|---|---|
| 6530 Q-TOF/C18 POSITIVE ION MODE | HOMOCYSTEINE (M+H)+ | 5047 | Peak area | IPMN | LGD |
| 6530 Q-TOF/C18 POSITIVE ION MODE | HOMOCYSTEINE (M+H)+ | 6847 | Peak area | IPMN | LGD |
| 6530 Q-TOF/C18 POSITIVE ION MODE | HOMOCYSTEINE (M+H)+ | 11773 | Peak area | MCN | LGD |
| 6530 Q-TOF/C18 POSITIVE ION MODE | HOMOCYSTEINE (M+H)+ | 13772 | Peak area | MCN | LGD |
| 6530 Q-TOF/C18 POSITIVE ION MODE | HOMOCYSTEINE (M+H)+ | 20269 | Peak area | IPMN | LGD |
| 6530 Q-TOF/C18 POSITIVE ION MODE | HOMOCYSTEINE (M+H)+ | 33826 | Peak area | SCA | N/A |
| 6530 Q-TOF/C18 POSITIVE ION MODE | HOMOCYSTEINE (M+H)+ | Peak area | IPMN | LGD | |
| 6530 Q-TOF/C18 POSITIVE ION MODE | HOMOCYSTEINE (M+H)+ | Peak area | MCN | LGD | |
| 6530 Q-TOF/C18 POSITIVE ION MODE | HOMOCYSTEINE (M+H)+ | Peak area | SCA | N/A |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|